Successful treatment of partial graft failure after matched unrelated donor stem cell transplantation by a combination of ancestim (stem cell factor) and granulocyte colony stimulating factor in a patient with heavily pre-treated chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 49, Issue 10, 2008, Pages 2015-2017

  Körper, Sixten ^a   Hütter, Gero ^a   Blau, Wolfgang ^a   Blau, Olga ^a   Schrezenmeier, Hubert ^a   Knauf, Wolfgang ^a   Thiel, Eckhard ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; BLOOD CLOTTING FACTOR 13 CONCENTRATE; CYCLOSPORIN A; FLUDARABINE; HLA DPB1 ANTIGEN; METHOTREXATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT STEM CELL FACTOR; RITUXIMAB; THYMOCYTE ANTIBODY; TREOSULFAN;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; BLOOD CELL COUNT; BONE MARROW BIOPSY; BONE MARROW EXAMINATION; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; COLONOSCOPY; CONFERENCE PAPER; ERYTHROCYTE TRANSFUSION; GASTROINTESTINAL HEMORRHAGE; GASTROSCOPY; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; LYMPHOCYTIC INFILTRATION; MALE; MUCOSAL BLEEDING; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS;

DRUG THERAPY, COMBINATION; GRAFT REJECTION; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; STEM CELL FACTOR; TREATMENT OUTCOME;

EID: 55049090226     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802304958     Document Type: Conference Paper

References (5)

1. Wolff, S. N. (2002) Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation. Bone Marrow Transplant, 29, pp. 545-552.
2. Kurzrock, R., Gratwohl, A., Paquette, M., Wyres, M., Okamoto, D. and Young, N. (1998) Trilineage responses seen with stem cell factor (stemgen, SCF) and filgastrim (G-CSF) treatment in aplastic anemia (AA) patients. Br J Haematol, 102, p. 1.
3. Schrezenmeier, H., Rio, B., Camitta, B., Paquette, R., Socie, G. Germing, U. et al. (2001) A randomized controlled study of ancestim (r-met human Stem Cell Factor, SCF) in newly diagnosed severe or very severe aplastic anemia patients receiving antithymocyte globulin, cyclosporine A and filgastrim. Bone Marrow Transplant, 27, p. S64.
4. Grothaus-Pinke, B., Gunzelmann, S., Fauser, A. A. and Kiehl, M. G. (2001) Factor XIII replacement in stem cell transplant (SCT) recipients with severe graft-versus-host disease of the bowel: Report of an initial experience. Transplantation, 72, pp. 1456-1458.
5. Casper, J., Knauf, W., Kiefer, T., Wolff, D., Steiner, B. Hammer, U. et al. (2004) Treosulfan and fludarabine: A new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation. Blood, 103, pp. 725-731.